US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

111.17

-0.4966-0.44%

Post-market: 111.170.00000.00%19:30 EDT

Volume:141.85K

Turnover:15.75M

Market Cap:1.00B

PE:90.08

High:111.66

Open:111.56

Low:110.63

Close:111.67

52wk High:118.00

52wk Low:85.91

Shares:9.04M

Float Shares:9.04M

Volume Ratio:0.80

T/O Rate:1.57%

Dividend:2.18

Dividend Rate:1.96%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):143.17

Loading ...

Overview Company News Filings

Sandoz Receives Marketing Authorization for Generic Version of Ozempic in Canada

MT Newswires Live

Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion

When Weight Loss Isn't the Goal of Taking a GLP-1

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Novo Nordisk Wins EMA Panel Backing for New Haemophilia A Therapy FREHEMGO

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

Novo Nordisk A/S Stock (NVO) Moved Up by 3.02% on Sep 17: What Signal Does It Send?

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

Cboe data suggests bullish flow in Novo Nordisk with shares up 3.3%

Novo Nordisk's Frehemgo to Treat Haemophilia A Receives CHMP Recommendation for EU Approval

MT Newswires Live

Novo Nordisk reports CHMP adopts positive opinion on MAA for Frehemgo

Novo Nordisk: Market Perform and $47 Price Target Maintained Amid Obesity Strength and Competitive Risks

Niagen Bioscience Names Martin Hendrix Strategic Adviser for Corporate Strategy, M&A

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live

AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement

Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig

Novo, Orbis Sign up to $1.4 Billion Deal to Develop Oral Drugs

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PPH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":111.17,"timestamp":1789761600000,"preClose":111.6666,"halted":0,"volume":141849,"hourTrading":{"tag":"盘后","latestPrice":111.17,"preClose":111.17,"latestTime":"19:30 EDT","volume":67,"amount":7448.39,"timestamp":1789774206363,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004447166834129461,"floatShares":9038138,"shares":9038138,"eps":1.234146,"marketStatus":"Market Closed","change":-0.4966,"latestTime":"09-18 16:00:00 EDT","open":111.56,"high":111.66,"low":110.63,"amount":15747897.25026,"amplitude":0.009224,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":111.6666,"sharesOutstanding":11938138,"nav":111.19945,"aum":999476026.97,"dividendRate":0.019581,"bidAskSpread":0.000458,"preHourTrading":{"tag":"盘前","latestPrice":111.787,"preClose":111.6666,"latestTime":"07:40 EDT","volume":15,"amount":1676.805,"timestamp":1789731644567,"change":0.1204,"changeRate":0.001078,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":111.17,"preClose":111.17,"latestTime":"19:30 EDT","volume":67,"amount":7448.39,"timestamp":1789774206363,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.796594807499508,"impliedVol":0.2232,"impliedVolPercentile":0.8048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9038138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.796594807499508,"shares":9038138,"dividePrice":2.1768,"high":111.66,"amplitude":0.009224,"preClose":111.6666,"low":110.63,"week52Low":85.9086,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":111.17,"eps":1.234146,"divideRate":0.019581,"volume":141849,"delay":0,"ttmEps":1.234146,"open":111.56,"prevYearClose":103.17,"prevWeekClose":109.44,"prevMonthClose":113.08,"prevQuarterClose":109.35,"fiveDayClose":109.44,"twentyDayClose":115.08,"sixtyDayClose":105.7343},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"},{"date":"2025-07-01","symbol":"PPH","amount":0.6069,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668949215","title":"Sandoz Receives Marketing Authorization for Generic Version of Ozempic in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2668949215","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668949215?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:45","pubTimestamp":1789721117,"startTime":"0","endTime":"0","summary":"Sandoz has received Health Canada's marketing authorization for its Semaglutide product, which is a generic version of Novo Nordisk's  Ozempic, according to a Friday statement.The approval expands patient access to semaglutide treatment in Canada, Sandoz said.Sandoz said the weekly injection is approved for adults with type 2 diabetes and will be offered in three strengths across two pen devices.According to the company, the US Food and Drug Administration has also recently accepted its application for the in-house development of generic tirzepatide, and the Owozy semaglutide product, for which it holds commercial rights, has been approved in Brazil.Sandoz said the approval will not alter its 2026 financial outlook, with no meaningful contribution from generic semaglutide expected this year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4532","SDZNY","NVO","OZEM","BK4599","BK4588","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","NVOC","BK4007","NVOX","THNR","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131230465","title":"Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1131230465","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131230465?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:54","pubTimestamp":1789696466,"startTime":"0","endTime":"0","summary":"A recent industry analysis warns that over the next decade, nearly 90% of biologic drugs losing their market exclusivity will lack a corresponding biosimilar in development, creating a significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2473716301.USD","LU2272731782.SGD","IBB","LU2322448957.HKD","LU2272731865.HKD","XPH","IE00B5TLWC47.USD","LU1992135399.USD","BK4588","159891","LU1992135472.HKD","BK4585","PPH","LU2272731600.USD","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668915626","title":"When Weight Loss Isn't the Goal of Taking a GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2668915626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668915626?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:00","pubTimestamp":1789693200,"startTime":"0","endTime":"0","summary":"At 5 feet 11 inches and 138 pounds, Ali Balkey has always been thin.So it might seem surprising that the 41-year-old Dallas, Texas real-estate investor says she has been taking a compounded version of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","IE00BJJMRX11.SGD","LU1814569148.SGD","LU0158827948.USD","LU2237443549.SGD","NVOH","IE00B4R5TH58.HKD","LLYZ","LU0345770993.USD","IE0002141913.USD","IE00BZ1G4Q59.USD","LU0787776722.HKD","IE00BKPKM429.USD","LU1061106388.HKD","LU2491049909.HKD","LU0133085943.USD","LU2265009873.SGD","LU2168563687.JPY","LU1983299246.USD","SG9999018857.SGD","LU0466842654.USD","CANC","LU0198837287.USD","LU0234572021.USD","LU1023059063.AUD","SGXZ81514606.USD","LU0320765992.SGD","LU1291159041.SGD","LU0353189680.USD","IYH","LU1988902786.USD","LU2023250330.USD","LU0203202063.USD","LU2111349929.HKD","LU1720051017.SGD","LU1267930730.SGD","LU2237438978.USD","LU2417539215.USD","OZEM","SG9999001176.USD","SG9999015978.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU0256863811.USD","LU2361044949.HKD","SG9999014906.USD","BK4534","LU0672654240.SGD","LU0238689110.USD","LU2087625088.SGD","LU2063271972.USD","LU2168564222.USD","LU2023250504.SGD","LU2211815571.USD","LU0820561818.USD","SGXZ57979304.SGD","LU0943347566.SGD","LU1712237335.SGD","LU2602419157.SGD","IE00B2B36J28.USD","LU1035775433.USD","SG9999015945.SGD","LU2491050154.USD","IE00BKDWB100.SGD","LU1145028129.USD","IE00B1BXHZ80.USD","THNR","BK4532","LU2213496289.HKD","LU0097036916.USD","LU2462591350.SGD","IE00BK4W5L77.USD","LU2237443382.USD","LU2089984988.USD","SGXZ99366536.SGD","IE0005OL40V9.USD","LU0289739699.SGD","LU2271345857.HKD","LU2462157665.USD","BK4533","LU2756315318.SGD","LU0210536198.USD","SG9999014898.SGD","LU2461242641.AUD","SG9999013999.USD","LU0106261372.USD","LU1323610961.USD","LU2552382215.SGD","LU1280957306.USD","LU2237443895.HKD","AGNG","IE00BJLML261.HKD","LU0964807845.USD","LU0154236417.USD","LU0225283273.USD","LU2896262040.SGD","LU1868836757.USD","LU2468319806.SGD","IE0009355771.USD","GB00BDT5M118.USD","LU1069344957.HKD","GDOC","FHLC","SG9999015952.SGD","LU2471134523.USD","LU2361044865.SGD","LU2471134952.CNY","LU2108987350.USD","LLY","LU0823416689.USD","LU2237443978.SGD","LU0385154629.USD","LU1868836914.USD","LU1917777945.USD","IE00B1XK9C88.USD","LU2746668461.USD","LU1548497426.USD","LU0061475181.USD","LU1366192091.USD","IE0004445239.USD","LU2023251221.USD","LU2456880835.USD","BK4581","RXL","ELIL","IE00BFTCPJ56.SGD","CURE","LU1868837136.USD","LU2112291526.USD","IE00BFSS7M15.SGD","LU2237443622.USD","BK4588","LU0471298777.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0174119429.USD","LU2168564065.EUR","IE00BJJMRY28.SGD","LU0323591593.USD","LU2236285917.USD","LU0345770308.USD","LU1623119135.USD","SG9999001176.SGD","IHE","BK4007","LU2168564495.EUR","SG9999014880.SGD","XLV","NVOX","SG9999015986.USD","LU1232071149.USD","TRUH","LU0354030438.USD","LU1093756168.USD","LU1093756325.SGD","LU1974910355.USD","LU0079474960.USD","LU0122379950.USD","LU0820561909.HKD","LU2089284900.SGD","LU1979441026.SGD","LU1720051108.HKD","MEDI","LU1064131342.USD","LU2552382132.HKD","LU1127390331.HKD","LU0114720955.EUR","LU1629891620.HKD","LU1551013342.USD","SGXZ51526630.SGD","LU0432979614.USD","LU0096364046.USD","LU0640476718.USD","LU2028103732.USD","LU2552382058.USD","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0823434583.USD","LU0823434740.USD","LU2106854487.HKD","BK4599","LU2471134879.HKD","TMED","LU0708995401.HKD","WDNA","LU2750360997.AUD","LLYX","ELIS","NVO","LU2168564149.EUR","LU0353189763.USD","LU2491050071.SGD","LU0882574055.USD","LU0109391861.USD","FTXH","LU0266013472.USD","LU2471134796.USD","IE00B4JS1V06.HKD","ILDR","IXJ","LU0256863902.USD","LU0094547139.USD","LLII","LU2324357040.USD","SG9999014914.USD","IE00BKVL7J92.USD","LU2756315664.SGD","HRTS","LU0456855351.SGD","VHT","SG9999018865.SGD","IE00B775H168.HKD","LU0320765059.SGD","LU0889565916.HKD","LU1868837300.USD","LU0820562030.AUD","LU0354030511.USD","LU0109394709.USD","IE00BN29S564.USD","LU1868836591.USD","LU0158827781.USD","LU2264538146.SGD","LU0417517546.SGD","LU2360106947.USD","LU0786609619.USD","LU2089283258.USD","LU1804176565.USD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","BK4585","LU1057294990.SGD","PJP","IE00BFSS8Q28.SGD","IE00BWXC8680.SGD","LU0689472784.USD","LU0882574139.USD","LU1989771016.USD","IE0004445015.USD","PPH","LU2361045086.USD","LU0203201768.USD","LU0683600562.USD","IE00B7KXQ091.USD","LU1691799644.USD","MHIP","LU0316494557.USD","LU2746668974.SGD","LU2357305700.SGD","NVOC","LU0006306889.USD","BK4516","LU2750360641.GBP","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668960992","title":"Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668960992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668960992?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:31","pubTimestamp":1789677060,"startTime":"0","endTime":"0","summary":"DJ Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  rallied 1.28% to $1,152.44 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Eli Lilly & Co. closed 10.85% short of its 52-week high of $1,292.65, which the company achieved on August 19th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and AbbVie Inc.  rose 0.58% to $264.02.Trading volume  remained 629,541 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1804176565.USD","BK4581","LU0689472784.USD","LU0432979614.USD","LU0198837287.USD","LU1093756168.USD","LU1145028129.USD","LU2417539215.USD","LU2602419157.SGD","LU2063271972.USD","SG9999001176.SGD","LU2471134879.HKD","LU0061475181.USD","LU1023059063.AUD","LU1988902786.USD","LU1093756325.SGD","BK4516","LU0158827781.USD","LU1814569148.SGD","LU0238689110.USD","LU1035775433.USD","IE00BFSS7M15.SGD","LU0079474960.USD","LU1868836757.USD","LU2471134523.USD","MEDX","IYH","LU1280957306.USD","LU1232071149.USD","LU1551013342.USD","LU1629891620.HKD","LU2168564065.EUR","LU2471134796.USD","LU2896262040.SGD","SG9999015952.SGD","LU0417517546.SGD","LU0823434740.USD","LU2264538146.SGD","LU0210536198.USD","LU2023251221.USD","LLY","FHLC","IE00B4JS1V06.HKD","SG9999015978.USD","LU2106854487.HKD","SG9999015986.USD","LU0471298694.HKD","BK4007","IE00BWXC8680.SGD","LU2324357040.USD","LU1974910355.USD","CANC","LU2023250504.SGD","LU1868836591.USD","LU1979441026.SGD","LU0094547139.USD","PPH","LU1061106388.HKD","SG9999015945.SGD","LU0106261372.USD","LU2746668974.SGD","LU1291159041.SGD","LU1868836914.USD","LU0823434583.USD","BK4534","LU0225283273.USD","LU2750360641.GBP","LU0256863811.USD","BK4585","LU0097036916.USD","IE00BN29S564.USD","LU0133085943.USD","BK4599","LU0471298777.SGD","LU2491050071.SGD","LU1267930730.SGD","LU2087625088.SGD","LU1691799644.USD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","LU2237443382.USD","LU2756315664.SGD","LU0820562030.AUD","LU2236285917.USD","LU2028103732.USD","LU2468319806.SGD","LU0109394709.USD","LU2361045086.USD","LU2361044949.HKD","IE00B775H168.HKD","SGXZ99366536.SGD","SG9999014898.SGD","LU0320765992.SGD","LU0823416689.USD","LU2746668461.USD","LU2491049909.HKD","LU1720051108.HKD","LU2213496289.HKD","RXL","LU0058720904.USD","LU2237438978.USD","LU2111349929.HKD","SG9999013999.USD","LU2237443895.HKD","LU2462157665.USD","GDOC","XLV","LU0385154629.USD","IE00BK4W5M84.HKD","PJP","LLYX","LU0316494557.USD","IE00B4R5TH58.HKD","LU0234572021.USD","LU0889565916.HKD","IE0004445015.USD","IE00BFSS8Q28.SGD","LU2552382058.USD","FTXH","IE0009355771.USD","JDOC","LU2552382215.SGD","LU2361044865.SGD","LU0320765059.SGD","LU0096364046.USD","LU0122379950.USD","SG9999018865.SGD","VHT","SG9999014906.USD","IE00BKPKM429.USD","TMED","LU1548497426.USD","IE00BK4W5L77.USD","LU2108987350.USD","LU1127390331.HKD","ELIL","BK4588","LU2237443978.SGD","LU1323610961.USD","IE00BKDWB100.SGD","LU2168564149.EUR","LU0354030438.USD","LU0820561818.USD","LU2462591350.SGD","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU2750360997.AUD","LU1989771016.USD","LU2471134952.CNY","LU0345770993.USD","LU2461242641.AUD","LU0158827948.USD","IE00BJLML261.HKD","LU2168564495.EUR","SG9999014880.SGD","LU0456855351.SGD","THNR","LU1366192091.USD","LU1917777945.USD","AGNG","LU0820561909.HKD","SGXZ81514606.USD","SG9999017495.SGD","ELIS","SGXZ31699556.SGD","LU1720051017.SGD","LU0353189680.USD","LU0672654240.SGD","LU1623119135.USD","LU0683600562.USD","LU1983299246.USD","OZEM","LU1069344957.HKD","IE0001KFT4U8.USD","LU2756315318.SGD","LU0786609619.USD","MEDI","LU0787776722.HKD","LU0882574139.USD","LU1712237335.SGD","CURE","IE00B7KXQ091.USD","LU0323591593.USD","LU0943347566.SGD","LU1551013425.SGD","LU2237443465.HKD","LU2089284900.SGD","SG9999001176.USD","LU2271345857.HKD","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0353189763.USD","IE0002141913.USD","LU1868837136.USD","MHIP","WDNA","SG9999018857.SGD","HRTS","SG9999014914.USD","LU2357305700.SGD","IE00BJJMRX11.SGD","LU0256863902.USD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU2023250330.USD","IE00B2B36J28.USD","LLYZ","LU2089984988.USD","LU0203202063.USD","LU2237443622.USD","LU2265009873.SGD","LU0174119429.USD","LU0964807845.USD","LU2089283258.USD","LLII","LU0640476718.USD","LU1868837300.USD","LU2491050154.USD","LU0114720955.EUR","LU2112291526.USD","LU0466842654.USD","ILDR","LU2237443549.SGD","BK4533","LU2456880835.USD","LU2168564222.USD","LU0345770308.USD","IE00BJT1NW94.SGD","LU2168563687.JPY","LU0354030511.USD","IHE","LU0203201768.USD","TRUH","LU0006306889.USD","IXJ","IE0004445239.USD","GB00BDT5M118.USD","LU2552382132.HKD","IE00B1XK9C88.USD","LU1064131342.USD","SGXZ51526630.SGD","LU2211815571.USD","LU0289739699.SGD","LU0266013472.USD","LU0708995401.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999182","title":"Novo Nordisk Wins EMA Panel Backing for New Haemophilia A Therapy FREHEMGO","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999182","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999182?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:57","pubTimestamp":1789664236,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has issued an announcement. Novo Nordisk announced on 17 September 2026 that the European Medicines Agency’s Committee for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-ema-panel-backing-for-new-haemophilia-a-therapy-frehemgo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-wins-ema-panel-backing-for-new-haemophilia-a-therapy-frehemgo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU0154236417.USD","NVO","IE00BKVL7J92.USD","NVOC","LU1093756168.USD","BK4532","LU1093756325.SGD","BK4588","BK4007","NVOH","NVOX","PPH","THNR","OZEM","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999880","title":"Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999880","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999880?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:32","pubTimestamp":1789662720,"startTime":"0","endTime":"0","summary":"Moderna stock abruptly rallied on Thursday, pacing toward its best session since a positive update for its experimental cancer vaccine sent shares skyrocketing.Look to no other explanation than a mome","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909247.SGD","HRTS","XLV","LU0861579265.USD","LU1162221912.USD","LU2125909593.SGD","LU1032466523.USD","IHE","LU1934455277.USD","SG9999013999.USD","IDNA","BK4534","LU1037948897.HKD","MRNX","LU1571399168.USD","JDOC","SG9999014575.USD","BK4551","MRNY","LU1974910355.USD","WDNA","RXL","LU1983299246.USD","FTXH","IE00B1BXHZ80.USD","IXJ","LGHT","VHT","PAWZ","LU0162691827.USD","LU0211331839.USD","LU2106854487.HKD","TRUH","IE00BN8TJ469.HKD","LU0124676726.USD","LU0069063385.USD","LU0965509283.SGD","PPH","SGXZ57979304.SGD","LU0122379950.USD","BMED","GDOC","GNOM","IYH","MRNA","LU1201861249.SGD","FHLC","LU2491050071.SGD","MRK","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668099939","title":"AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2668099939","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668099939?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662616,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest dry eye study compares its new ABBV-444 artificial tear against...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-dry-eye-market-upside-with-new-abbv-444-trial-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-dry-eye-market-upside-with-new-abbv-444-trial-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B42XCP33.USD","XLV","SG9999003800.SGD","JDOC","IE00BVYPNW00.USD","LU0545039389.USD","MEDX","IE00BSNM7G36.USD","LU0708994859.HKD","IYH","PJP","LU1236620750.USD","BK4534","PPH","LU2347655073.USD","VHT","LU0122379950.USD","IE00BVYPNV92.GBP","LU0912757837.SGD","LU2237443978.SGD","SG9999015952.SGD","LU2129689605.HKD","LU2089283258.USD","LU0689626769.HKD","LU1291159041.SGD","LU2129689431.USD","LU1983299246.USD","FTXH","FHLC","LU1934455277.USD","AGNG","GLAM","ABBV","LU1244550221.USD","LU1989771016.USD","LU1923622614.USD","IE000F7OJYX1.SGD","IE00BLSP4452.SGD","LU2023251221.USD","IE0002270589.USD","IE00BLSP4239.USD","LU1929549753.HKD","LU0795875169.SGD","LU0985320562.USD","LU0211328371.USD","LU1548497426.USD","RXL","TRUH","IXJ","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999582","title":"Novo Nordisk A/S Stock (NVO) Moved Up by 3.02% on Sep 17: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999582","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999582?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:15","pubTimestamp":1789661722,"startTime":"0","endTime":"0","summary":"• Novo Nordisk partnered with Orbis Medicine for AI-driven oral cardiometabolic drug discovery.\n• European regulators issued a favorable marketing recommendation for Frehemgo in hemophilia A.\n• The company reported $46.70B in annual revenue and $15.48B in net profit.","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262173629-market-movers-nvo-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","BK4588","NVOH","NVOX","NVOC","BK4585","OZEM","PPH","THNR","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU1093756168.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996113","title":"US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996113","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996113?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:09","pubTimestamp":1789661363,"startTime":"0","endTime":"0","summary":"UPDATE 2-US regulators urge more research on testosterone therapy for women as experts debate benefits, risksSept 17 (Reuters)-US health regulators on Thursday called for more data on testosterone the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL1N4590J9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","IE00BGHQF631.EUR","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1989772923.USD","RXL","LU2237443622.USD","BK4581","MEDX","IXJ","XLV","BK4588","IE00BFTCPJ56.SGD","LU1720051017.SGD","BK4139","FHLC","LU0256863811.USD","TRUH","VHT","IYH","PPH","AGNG","GLAM","LU0234572021.USD","LU0553294199.USD","IE00BVYPNV92.GBP","LU1244550577.SGD","IE00B42XCP33.USD","LU0057025933.USD","LU1093756168.USD","LU0198837287.USD","LU0689626769.HKD","IE00B19Z3581.USD","JDOC","IE00BSNM7G36.USD","FTXH","LU0456855351.SGD","LU1551013342.USD","LU2433249047.HKD","ABBV","LU2129689431.USD","LU1496350502.SGD","LU2087621335.USD","LU2468319806.SGD","LU0472753341.HKD","PJP","IE000MB6IJN5.SGD","SG9999015945.SGD","LU1585245621.USD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668201995","title":"Cboe data suggests bullish flow in Novo Nordisk with shares up 3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668201995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668201995?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:40","pubTimestamp":1789659620,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Novo Nordisk (NVO), with shares up $1.38, or 3.3%, near $43.09. Options volume running well above average with 3...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","PPH","OZEM","NVOX","IE00BKVL7J92.USD","BK4585","BK4532","BK4599","BK4007","LU1093756168.USD","NVO","NVOH","THNR","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668745993","title":"Novo Nordisk's Frehemgo to Treat Haemophilia A Receives CHMP Recommendation for EU Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2668745993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668745993?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:57","pubTimestamp":1789657021,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Thursday that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization for Frehemgo or denecimig in the European Union to treat haemophilia A, a bleeding disorder.CHMP's positive opinion is based on the company's trial data that showed denecimig reduced annualised bleeding rate compared with prior clotting factor prophylaxis and on-demand treatment in patients, according to a statement.The company said it expects to launch Frehemgo in European countries from Q4 onwards.Price: 42.88, Change: +1.17, Percent Change: +2.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","NVOC","PPH","BK4585","BK4007","BK4588","BK4532","LU0154236417.USD","NVOH","NVOX","IE00BKVL7J92.USD","THNR","LU1093756168.USD","OZEM","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993171","title":"Novo Nordisk reports CHMP adopts positive opinion on MAA for Frehemgo","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993171","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993171?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:30","pubTimestamp":1789655437,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-reports-chmp-adopts-positive-opinion-on-maa-for-frehemgo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-reports-chmp-adopts-positive-opinion-on-maa-for-frehemgo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","BK4532","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","LU0154236417.USD","NVOC","OZEM","NVOH","BK4585","PPH","BK4599","IE00BZ1G4Q59.USD","NVO","THNR","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668960041","title":"Novo Nordisk: Market Perform and $47 Price Target Maintained Amid Obesity Strength and Competitive Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668960041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668960041?lang=en_us&edition=fundamental","pubTime":"2026-09-17 21:35","pubTimestamp":1789652141,"startTime":"0","endTime":"0","summary":"Novo Nordisk, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Evan Seigerman from BMO Capital maintained a Hol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/novo-nordisk-market-perform-and-47-price-target-maintained-amid-obesity-strength-and-competitive-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/novo-nordisk-market-perform-and-47-price-target-maintained-amid-obesity-strength-and-competitive-risks-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","OZEM","BK4007","BK4599","LU0154236417.USD","NVOC","NVOX","PPH","BK4588","BK4585","NVOH","LU1093756325.SGD","THNR","NVO","BK4532","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962129","title":"Niagen Bioscience Names Martin Hendrix Strategic Adviser for Corporate Strategy, M&A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962129","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962129?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:32","pubTimestamp":1789648373,"startTime":"0","endTime":"0","summary":"Niagen Bioscience names Martin Hendrix strategic adviser for corporate strategy, M&ANiagen Bioscience’s NAD Pharmaceuticals unit engaged Red Sky Partners as strategic adviser to advance NB4168, a smal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL7b0CW9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2089284900.SGD","LU1244550494.USD","FTXH","FHLC","TRUH","IE00B42XCP33.USD","LU0868494708.USD","LU1291159041.SGD","LU0689472784.USD","LU0158827948.USD","LU0124676726.USD","LU1670627923.USD","LU0965509283.SGD","LU1548497426.USD","PPH","LU0859254822.USD","SG9999015978.USD","JDOC","LU1983299246.USD","LU0170899867.USD","LU0057025933.USD","LU0726765562.USD","LU2129689431.USD","IE00B2B36J28.USD","LU2347655073.USD","IE0002141913.USD","LU0545039389.USD","NAGE","LU1670628061.USD","IXJ","LU0256863902.USD","LU2089984988.USD","GLAM","LU2237443465.HKD","LU1551013342.USD","LU0738911758.USD","ABBV","RXL","XLV","LU1585245621.USD","SG9999015986.USD","MEDX","PJP","VHT","IYH","LU2237443382.USD","LU1839511570.USD","LU1732800096.USD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964039","title":"Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964039","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668964039?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:11","pubTimestamp":1789647110,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company (LLY) has an average rating of overweight and mean price target of $1,359.06, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU0061475181.USD","IE00BFTCPJ56.SGD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1061106388.HKD","RXL","LU0114720955.EUR","LU2168563687.JPY","SGXZ57979304.SGD","SG9999015978.USD","LU0058720904.USD","BK4588","LU1712237335.SGD","LU2462591350.SGD","IE00BJJMRZ35.SGD","LU0823434583.USD","AGNG","IE00BJJMRX11.SGD","LU2471134523.USD","LU2211815571.USD","LU0256863811.USD","SG9999015986.USD","SG9999001176.USD","LU2023251221.USD","TMED","LU2237438978.USD","LU1629891620.HKD","LU0122379950.USD","LU2746668974.SGD","CANC","LU2236285917.USD","LLYX","LU0096364046.USD","LU0097036916.USD","LU0354030438.USD","LU0238689110.USD","LU0345770308.USD","LU0353189763.USD","LU0820561909.HKD","LU2471134796.USD","LU2089984988.USD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","LU0106261372.USD","LU0158827948.USD","LU2471134879.HKD","LU2168564065.EUR","LU0320765992.SGD","LU0889565916.HKD","LU2265009873.SGD","VHT","LU2361044865.SGD","SG9999018857.SGD","IE00BFSS8Q28.SGD","LU0456855351.SGD","SG9999014906.USD","LU2360106947.USD","LU2417539215.USD","LU0133085943.USD","LU1093756168.USD","IE0005OL40V9.USD","LU2028103732.USD","OZEM","LU2237443978.SGD","LU0320765059.SGD","LU0787776722.HKD","SG9999015945.SGD","LU1323610961.USD","IE0004445239.USD","LU1035775433.USD","LU0882574139.USD","LU0640476718.USD","LU0683600562.USD","LU0943347566.SGD","LU0823434740.USD","LU0964807845.USD","IE0009355771.USD","LU2462157665.USD","SG9999018865.SGD","SG9999001176.SGD","WDNA","LU2112291526.USD","IE00B4JS1V06.HKD","LU2237443622.USD","LU0672654240.SGD","LU2552382058.USD","BK4585","IE00BJLML261.HKD","LU0786609619.USD","IE0002141913.USD","LU0203202063.USD","LU0158827781.USD","LU1291159041.SGD","LU1974910355.USD","LU0210536198.USD","LU1366192091.USD","IE00B2B36J28.USD","MHIP","LU2271345857.HKD","LU0174119429.USD","LU2746668461.USD","FHLC","LLII","LU1868836757.USD","IE00B4R5TH58.HKD","TRUH","LU2324357040.USD","LU1868837300.USD","LU0471298694.HKD","LU2168564222.USD","LU2602419157.SGD","LU0353189680.USD","SGXZ99366536.SGD","ILDR","IE00B775H168.HKD","LU2106854487.HKD","LU0266013472.USD","LU2552382132.HKD","BK4516","LU2213496289.HKD","SG9999014914.USD","SGXZ51526630.SGD","LU0385154629.USD","LU2063271972.USD","LU2491049909.HKD","LU1057294990.SGD","ELIS","BK4534","LU1232071149.USD","SG9999014880.SGD","PJP","LU2237443382.USD","LU1868836591.USD","ELIL","XLV","LU2750360641.GBP","IE0004445015.USD","LU1551013342.USD","LU0234572021.USD","FTXH","LU0471298777.SGD","IXJ","SG9999017495.SGD","LU2237443895.HKD","LU1267930730.SGD","HRTS","IE0001KFT4U8.USD","LU1145028129.USD","LU1983299246.USD","LU2023250330.USD","JDOC","LU0820561818.USD","IE00BKPKM429.USD","LU1917777945.USD","BK4533","LU1979441026.SGD","CURE","LU1623119135.USD","LU2491050071.SGD","IE00BJT1NW94.SGD","GDOC","IE00BFSS7M15.SGD","LU0109391861.USD","LU0225283273.USD","LU0708995401.HKD","BK4599","LLYZ","LU0466842654.USD","LU0882574055.USD","LU1988902786.USD","LU2491050154.USD","LU0823416689.USD","LU1280957306.USD","LLY","LU0323591593.USD","LU1804176565.USD","LU1720051108.HKD","LU2361045086.USD","SG9999015952.SGD","LU2089283258.USD","THNR","LU1814569148.SGD","LU2111349929.HKD","LU2087625088.SGD","IE00BN29S564.USD","LU1127390331.HKD","SG9999014898.SGD","IE00BK4W5L77.USD","IHE","SGXZ31699556.SGD","LU1093756325.SGD","LU2357305700.SGD","LU0094547139.USD","IYH","LU0417517546.SGD","LU0354030511.USD","LU2461242641.AUD","LU0203201768.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU2023250504.SGD","LU2168564149.EUR","LU2456880835.USD","MEDX","LU1691799644.USD","PPH","LU1551013425.SGD","LU0432979614.USD","LU2896262040.SGD","LU2168564495.EUR","LU0316494557.USD","LU1720051017.SGD","LU0109394709.USD","LU0198837287.USD","LU0289739699.SGD","LU0079474960.USD","LU1868836914.USD","LU2468319806.SGD","LU2108987350.USD","LU1069344957.HKD","LU2237443465.HKD","SGXZ81514606.USD","LU0006306889.USD","LU2237443549.SGD","LU0345770993.USD","LU2756315318.SGD","LU1868837136.USD","LU1023059063.AUD","LU2089284900.SGD","LU2361044949.HKD","MEDI","IE00BWXC8680.SGD","BK4581","LU1548497426.USD","LU2552382215.SGD","LU2750360997.AUD","IE00BKDWB100.SGD","LU0689472784.USD","SG9999013999.USD","LU2756315664.SGD","LU0820562030.AUD","LU2471134952.CNY","LU1064131342.USD","IE00B1XK9C88.USD","IE00B7KXQ091.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668696237","title":"AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2668696237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668696237?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:10","pubTimestamp":1789647029,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) company Allergan Aesthetics announced results from two single-center clinical studies evaluating targeted skincare regimens alone and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-allergan-aesthetics-presents-clinical-data-on-skin-quality-improvement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-allergan-aesthetics-presents-clinical-data-on-skin-quality-improvement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1670627923.USD","FHLC","PJP","XLV","RXL","IXJ","LU2125909247.SGD","MEDX","LU0820561818.USD","TRUH","LU2023251221.USD","LU1548497426.USD","LU2468319806.SGD","LU0234570918.USD","JDOC","LU0098860793.USD","LU0965509283.SGD","LU0122379950.USD","LU0472753341.HKD","VHT","LU0058720904.USD","LU0738911758.USD","LU1720051108.HKD","LU1934455194.USD","IE0004445239.USD","LU1989772840.SGD","ABBV","LU0868494708.USD","GLAM","SG9999015978.USD","LU0289739699.SGD","LU0823416689.USD","IYH","LU1244550577.SGD","LU0256863811.USD","LU2089984988.USD","LU1496350502.SGD","FTXH","LU1732799900.SGD","LU1093756168.USD","IE0002270589.USD","BK4588","LU0320765646.SGD","LU0689472784.USD","LU1003077747.HKD","AGNG","IE0009355771.USD","LU1585245621.USD","PPH","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961347","title":"Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961347","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961347?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:20","pubTimestamp":1789644013,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) ‘announced that phase 3b results from the FRONTIER5 study of investigational denecimig were published in the Journal of Thrombos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-frontier5-phase-3b-results-for-denecimig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-frontier5-phase-3b-results-for-denecimig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","NVOX","NVOC","NVO","NVOH","BK4007","THNR","BK4585","BK4599","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969658","title":"Novo, Orbis Sign up to $1.4 Billion Deal to Develop Oral Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969658","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969658?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642800,"startTime":"0","endTime":"0","summary":"Novo, Orbis sign up to $1.4 billion deal to develop oral drugsSept 17 (Reuters)-Orbis Medicines said on Thursday it had signed a drug discovery and licensing deal with Novo NordiskNOVOb.COworth up to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N45817K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BKVL7J92.USD","LU1093756168.USD","NVO","THNR","IE00BZ1G4Q59.USD","BK4585","LU1093756325.SGD","NVOX","NVOH","BK4599","OZEM","NVOC","PPH","BK4532","BK4588","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668539799","title":"GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2668539799","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668539799?lang=en_us&edition=fundamental","pubTime":"2026-09-17 11:47","pubTimestamp":1789616828,"startTime":"0","endTime":"0","summary":"BUZZ-GenScript Biotech hits near 5-year high on Eli Lilly collaboration** Shares of GenScript Biotech Corp1548.HKjump 16.9% to HK$38.06, their highest level since December 2021** Stock on track for biggest one-day pct gain since July 2024, up for a second straight session** Top pct gainer in the Hang Seng Biotech Index.HSBIO, which rises 2.3%** GenScript says it has entered into collaboration with Lilly TuneLab, the AI/machine learning-based drug discovery collaboration platform of Eli Lilly and CompanyLLY.N** GenScript will provide wet lab services to companies participating in Lilly TuneLab, helping them rapidly generate experimental data, translate AI predictions into biologically validated data, and accelerate evaluation of drug candidates** YTD, stock has more than tripled in value, Hang Seng Biotech Index.HSBIOup 9.3%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL1N45903K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","OZEM","GB00BDT5M118.USD","LU0471298694.HKD","LLYX","LU2461242641.AUD","LU2271345857.HKD","ILDR","CURE","IE00BJLML261.HKD","LU1069344957.HKD","LU0889565916.HKD","LU2264538146.SGD","MEDX","LU1629891620.HKD","LU0320765992.SGD","LU2108987350.USD","LU0820561909.HKD","IE0001KFT4U8.USD","LU2462591350.SGD","SGXZ81514606.USD","LU1057294990.SGD","LU1280957306.USD","LU0353189763.USD","BK4585","AGNG","LU2237443465.HKD","LU0689472784.USD","IXJ","LU2237443978.SGD","LU1804176565.USD","LU2491049909.HKD","LU2491050071.SGD","IE00B775H168.HKD","LU0094547139.USD","LU0061475181.USD","LU2211815571.USD","LU2552382215.SGD","SG9999014880.SGD","HK0000320264.USD","SG9999015986.USD","LU2756315664.SGD","PJP","LU0109391861.USD","LU0323591593.USD","LU1979441026.SGD","LU0133085943.USD","LU1712237335.SGD","LU2471134796.USD","LU1023059063.AUD","VHT","FTXH","LU1917777945.USD","LU2087625088.SGD","LU1623119135.USD","LU2111349929.HKD","SG9999018857.SGD","IE00B1BXHZ80.USD","PPH","SG9999013999.USD","LU2168564065.EUR","SG9999015952.SGD","LU2471134879.HKD","IE0004445015.USD","LU2089284900.SGD","IE00BK4W5L77.USD","LU0203202063.USD","LU0786609619.USD","LU2360106947.USD","LU1983299246.USD","LU2756315318.SGD","BK1576","BK1141","LU0320765059.SGD","LU0823434740.USD","SGXZ31699556.SGD","IE00B7KXQ091.USD","IE00B1XK9C88.USD","IE0009355771.USD","LU0109394709.USD","SG9999014898.SGD","LU1551013425.SGD","LU0203201768.USD","LU2896262040.SGD","LU0964807845.USD","LU0787776722.HKD","IE00BJJMRY28.SGD","IE00BJJMRX11.SGD","LU2023250330.USD","BK4581","LU1868836591.USD","LU1323610961.USD","01548","LU0683600562.USD","IE00BKDWB100.SGD","BK4599","LU0672654240.SGD","LU1127390331.HKD","LU2168563687.JPY","LU2468319806.SGD","LU2746668974.SGD","SGXZ51526630.SGD","LU0114720955.EUR","LU2237443549.SGD","IE00B4R5TH58.HKD","LU2750360641.GBP","BK4533","BK4516","ELIS","LU0820562030.AUD","LU2361045086.USD","LU0640476718.USD","IE00BFTCPJ56.SGD","IE00BN29S564.USD","IYH","LU0174119429.USD","LU2089984988.USD","WDNA","TMED","LU1064131342.USD","LU1548497426.USD","LU2023251221.USD","THNR","LU0354030511.USD","LU0417517546.SGD","LU2168564222.USD","MEDI","LU0122379950.USD","LU1061106388.HKD","LU2236285917.USD","LU2063271972.USD","SG9999001176.SGD","LU0158827781.USD","SGXZ99366536.SGD","LU2471134523.USD","LU2491050154.USD","LU1868836914.USD","MHIP","SG9999001176.USD","IHE","LU0820561818.USD","LLY","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1814569148.SGD","IE00BFSS8Q28.SGD","BK4007","LU0266013472.USD","BK4588","LU0353189680.USD","JDOC","LU0354030438.USD","LU2106854487.HKD","LU2237443622.USD","SG9999015945.SGD","LU0289739699.SGD","LU2357305700.SGD","LU1868837136.USD","SG9999014914.USD","HK0000306701.USD","LU0882574139.USD","LU0882574055.USD","LU0823434583.USD","LU2265009873.SGD","LU1868836757.USD","LU0385154629.USD","LU2023250504.SGD","LU0234572021.USD","LU1093756325.SGD","LU0079474960.USD","SGXZ57979304.SGD","LU2471134952.CNY","LU0316494557.USD","LU2237443895.HKD","LU0345770308.USD","LU1145028129.USD","RXL","LU0823416689.USD","LU2361044949.HKD","LU2602419157.SGD","IE0005OL40V9.USD","LU0158827948.USD","LU0238689110.USD","LU1868837300.USD","IE0002141913.USD","LU1366192091.USD","LU0708995401.HKD","LU0198837287.USD","LU0106261372.USD","LU0210536198.USD","FHLC","IE00BK4W5M84.HKD","LU0006306889.USD","LU2089283258.USD","LU0943347566.SGD","LU1691799644.USD","LU1232071149.USD","LU2456880835.USD","XLV","HRTS","LU2417539215.USD","IE00BWXC8680.SGD","IE00B4JS1V06.HKD","LU0456855351.SGD","LU0058720904.USD","GDOC","IE00BFSS7M15.SGD","LU1035775433.USD","HK0000306685.HKD","LU2112291526.USD","SG9999018865.SGD","LU2361044865.SGD","CANC","LU1291159041.SGD","LU1551013342.USD","SG9999017495.SGD","LU2552382132.HKD","HK0000320223.HKD","LU2746668461.USD","LU0097036916.USD","LU2168564495.EUR","SG9999014906.USD","LLYZ","LU1093756168.USD","IE00BKPKM429.USD","ELIL","LU0096364046.USD","LU2237443382.USD","LU0471298777.SGD","LU1988902786.USD","LU2552382058.USD","LLII","LU0256863902.USD","SG9999015978.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","BK4534","LU0432979614.USD","LU2028103732.USD","LU0256863811.USD","LU0345770993.USD","LU1974910355.USD","IE0004445239.USD","LU1989771016.USD","LU2462157665.USD","LU2213496289.HKD","LU0466842654.USD","LU2750360997.AUD","LU1720051108.HKD","LU2168564149.EUR","LU1267930730.SGD","BK1583","TRUH","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668938436","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668938436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668938436?lang=en_us&edition=fundamental","pubTime":"2026-09-17 03:13","pubTimestamp":1789586017,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed late Wednesday afternoon, with the NYSE Healthcare Index fractionally lower and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  was 0.2% lower.In corporate news, Novo Nordisk  is collaborating with AI firm Anthropic to try to address key drug discovery challenges, develop targeted solutions and accelerate the development of new medicines, the companies said Wednesday. Novo shares were down 2.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4532","PPH","OZEM","BK4599","NVOC","IE00BKVL7J92.USD","NVOH","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4585","THNR","BK4588","BK4007","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":2,"totalSize":235,"code":"91000000","status":"200"}]}}